drugset / Trial / NCT04182932
Safety and Immunogenicity of CJ-40010 in Healthy Subjects
RandomizedSequentialQuadruple-blindPrevention
Summary
This study aims to evaluate the safety and immunogenicity of CJ-40010 after administration in healthy subjects
Timeline
- Start
- 2019-12-02
- Primary completion
- 2021-11
- Completion
- 2021-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | CJ-40010 Bivalent vaccine | Vaccine | — | — |
| Subject | CJ-40010 CVA16 vaccine | Vaccine | — | — |
| Subject | CJ-40010 EV71 vaccine | Vaccine | — | — |